Antibiotics for Prevention of SSI in Obese Women Undergoing CS

Combination Vs Single Antibiotics for Prevention of SSI in Obese Women Undergoing CS

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03736187

Enrollment

280

Registered

2018-11-09

Start date

2019-04-30

Completion date

2019-12-31

Last updated

2018-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Site Infection

Brief summary

Effect of cephalexin plus metronidazole on SSI better than cephalexin alone in obese women undergoing CS

Detailed description

Comparison between efficacy of cephalexin alone and cephalexin plus metronidazole on surgical site infection in obese women undergoing CS and follow up of any signs of wound infection

Interventions

DRUGCephalexin

Giving cephalexin and metronidazole in one group &cephalexin alone in another group

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Masking description

Two equal groups,140 women in each group

Intervention model description

2 Groups of obese women under elective cesarean section

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* obese women under elective CS

Exclusion criteria

* immunodeficient women

Design outcomes

Primary

Measure	Time frame	Description
Wound infection	One week	Fever, redness, ecchymosis and tenderness

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026